Mode
Text Size
Log in / Sign up

TEAS significantly reduces overall PONV risk in patients undergoing breast surgery compared to sham stimulation or routine careTEAS reduces nausea and pain for patients having breast surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider TEAS as a non-pharmacological adjunct to reduce PONV risk in breast surgery patients.

This systematic review and meta-analysis examined the efficacy of transcutaneous electrical acupoint stimulation (TEAS) as an adjunct for preventing postoperative nausea and vomiting in patients undergoing breast surgery. The analysis included 1,752 participants and compared TEAS against sham stimulation or routine care. The primary outcome was overall PONV incidence, while secondary outcomes included postoperative nausea, vomiting, pain scores, early recovery quality, and the need for rescue antiemetics.

The pooled analysis demonstrated that TEAS significantly reduced overall PONV risk with a relative risk of 0.61 (95% CI 0.49, 0.77; P < 0.01). The review also found lower rates of postoperative nausea and vomiting, reduced pain scores, improved early recovery quality scores, and a reduced need for rescue antiemetics. Specific effect sizes for these secondary outcomes were not reported.

Safety data, including adverse events and tolerability, were not reported in the source. The certainty of evidence was assessed using the GRADE approach. The authors highlight that further large-scale, sham-controlled RCTs are warranted to establish standardized protocols. Despite these limitations, the findings support the integration of TEAS into perioperative care as a non-pharmacological adjunct.

Nausea and vomiting after surgery can ruin a patient's recovery. For people undergoing breast surgery, these symptoms are common and distressing. A new analysis looked at a specific non-drug treatment called transcutaneous electrical acupoint stimulation, or TEAS. This method uses mild electrical currents applied to specific points on the skin to help calm the nausea reflex. The researchers combined data from many studies involving 1,752 patients to see if this approach truly helped.

The results were clear. TEAS significantly reduced the overall risk of postoperative nausea and vomiting. Patients who received this treatment also reported less nausea and less vomiting than those who received sham stimulation or standard care alone. Beyond just stopping the sickness, the treatment also led to lower pain scores and better early recovery quality scores. Fewer patients needed extra rescue medications to feel better.

The certainty of the evidence was assessed using the GRADE method. While the findings are promising, the study authors note that further large-scale, sham-controlled trials are warranted to establish standardized protocols. This means doctors need more data to agree on exactly how to apply the treatment. Still, the data supports integrating this non-pharmacological option into perioperative care plans.

What this means for you:
TEAS significantly reduces nausea and vomiting risk for patients having breast surgery.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Postoperative nausea and vomiting (PONV) remains a frequent challenge for patients undergoing breast cancer surgery. Transcutaneous electrical acupoint stimulation (TEAS) is increasingly utilized as a needle-free, neuromodulatory adjunct in perioperative care. Although a prior meta-analysis evaluated TEAS for PONV across general surgical populations, breast surgery-specific evidence remains lacking. This meta-analysis evaluates the efficacy of TEAS for preventing PONV and enhancing early recovery in this specific surgical population. We systematically searched PubMed, Embase, Cochrane Library, Web of Science, and three Chinese databases (CNKI, VIP, Wanfang) for randomized controlled trials (RCTs) comparing perioperative TEAS with sham stimulation or routine care, up to March 10, 2026. The primary outcome was overall PONV incidence. Secondary outcomes included postoperative nausea, vomiting, pain scores, and early recovery quality (QoR). Data were synthesized using RevMan 5.4, and the certainty of evidence was assessed with GRADE. Fifteen RCTs comprising 1,752 patients were included. TEAS significantly reduced overall PONV risk [RR = 0.61, 95% CI (0.49, 0.77), P < 0.01] with no heterogeneity (I2 = 0%). Patients receiving TEAS also experienced lower postoperative nausea, vomiting, pain scores, reduced need for rescue antiemetics, and improved early QoR scores. TEAS might be an effective and non-pharmacological adjunct for reducing PONV and supporting early recovery in breast cancer surgery. These findings support its integration into perioperative care, although further large-scale, sham-controlled RCTs are warranted to establish standardized protocols. https://www.crd.york.ac.uk/PROSPERO/view/CRD420261333755.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.